The eukaryotic cell is a very complex biological entity which undergoes dramatic structural and functional changes during the processes of cellular activation, differentiation and transformation. Human tumor cells are distinguished from their normal counter parts by the expression of proteins associated with the various respective genetic or epigenetic changes. High resolution two-dimensional (2D-) polyacrylamide gel electrophoresis which is capable of the simultaneous resolution of thousands of individual proteins has proven to be an important technique in the analysis of cellular protein expression. The enhanced resolution obtained by coupling 2D-gel resolution with different immunological and biochemical techniques has made it feasible to identify novel polypeptide gene products as well as post-translational modifications. Furthermore, with the use of computerized gel scanning and image processing it is possible to examine the patterns of gene expression of a given cell type, assign number to individual polypeptides, compare, quantitate and store the wealth of information contained in the gels. The LCRC 2D-gel facility is equipped with state-of-the-art technology and expertise for (1) the resolution of complex protein mixtures using ISO- DALT methods and subsequent immunological or biochemical analysis; (2) the capacity to perform computerized data analysis with the aid of ELSIE-5 program. During the past year, five peer reviewed funded projects have used the 2D-gel services and made substantial progress. Many additional projects plan to use the facility in the coming year. Currently, our approaches are directed to address topics such as I. Differential protein expression in (a) radioresistant vs. radiosensitive human tumors cells, (b) radiation-transformed human epithelial cells, (c) estrogen-responsive and estrogen-independent breast cancer cells; and II. Post-translational modifications (a) in response to DNA damage/repair with particular emphasis on ADP-ribosylation, (b) as mediators of cellular invasion in transformed cells in the form of tyrosine phosphorylation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-05
Application #
3751213
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Yichien; Rodriguez, Olga C; Albanese, Chris et al. (2018) Divergent brain changes in two audiogenic rat strains: A voxel-based morphometry and diffusion tensor imaging comparison of the genetically epilepsy prone rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Neurobiol Dis 111:80-90
Coia, Heidi; Ma, Ning; Hou, Yanqi et al. (2018) Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E. Cancer Prev Res (Phila) 11:665-676
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Ozawa, Patricia Midori Murobushi; Alkhilaiwi, Faris; Cavalli, Iglenir João et al. (2018) Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells. Breast Cancer Res Treat 172:713-723
Smith, Jill P; Wang, Shangzi; Nadella, Sandeep et al. (2018) Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother 67:195-207
Edwardson, Matthew A; Zhong, Xiaogang; Fiandaca, Massimo S et al. (2018) Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep 8:12558
Kaat, Aaron J; Schalet, Benjamin D; Rutsohn, Joshua et al. (2018) Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT). Cancer 124:153-160
Maximov, Philipp Y; Abderrahman, Balkees; Fanning, Sean W et al. (2018) Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Mol Pharmacol 94:812-822
Czarnecka, Magdalena; Lu, Congyi; Pons, Jennifer et al. (2018) Neuropeptide Y receptor interactions regulate its mitogenic activity. Neuropeptides :
Gonzalez, Thomas L; Moos, Rebecca K; Gersch, Christina L et al. (2018) Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines. Toxicol Sci 164:50-59

Showing the most recent 10 out of 1120 publications